TP53 and cancer: To study whether Δ133p53α mutation impacts its activities, we selected the R273H mutation since this is the most frequent mutation in GBM (13.5% and 11.8%) and the first or second most frequent mutation in cancers (6.4% and 5.9%) according to the COSMIC and TP53 databases3,25, respectively.